ロード中...
OMICS-based personalized oncology: if it is worth doing, it is worth doing well!
The era of Personalized Medicine implies getting the right treatment to the right patient at the right schedule and dose at the right time. Tumor biomarker tests are keys to accomplishing this goal successfully. However, much of the translational research regarding tumor biomarker tests has been hap...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3876724/ https://ncbi.nlm.nih.gov/pubmed/24228698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-11-221 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|